FSD Pharma is a publicly traded company on the Canadian Securities Exchange under the symbol HUGE. The Company, through its wholly-owned subsidiary FV Pharma Inc., holds an ACMPR license to cultivate cannabis under the Access to Cannabis for Medical Purposes Regulations (ACMPR). FSD, on its first day of trading on the Canadian Securities Exchange (“CSE”), broke the all-time record for volume traded, making the company the largest volume traded in a single first day of trading in the history of the CSE.

Health Canada ACMPR licensed producer

Existing 620,000 sq. ft. facility on 70 Acres, significant room for expansion

Planned stage-phased expansion to be the world’s largest indoor hydroponic facility

Facility Location & Accessibility

Our facility, the former Kraft food production plant in Cobourg, Ontario, approximately an hour’s drive from Toronto, has the potential to host over 3,800,000 sq. ft. of cultivation and processing area. Through this, FSD Pharma intends to target all legal aspects of the cannabis industry, including cultivation, processing, manufacturing, extracts and research and development.

View More Photos

Facility Highlights

Optimal Environment

Indoor hydroponic production facility = Highest quality controlled environment for large-scale pharmaceutical grade cannabis production

HUGE Size

620,000 sq. ft. of existing building space and sits on a 70-acre parcel of land, 30 acres currently utilized and 40 acres available for development

HUGE Growth

Planned staged-phased development of which once complete is expected to have 3,800,000 sq. ft. of cultivation and related ancillary businesses

In-House Operations

All operations under one roof which allows for economies of scale and operational efficiency

Accessible

Located 1 hour east of Toronto off the 401 highway and has access by car or rail to Ottawa and Montreal

Debt-Free

Facility is wholly owned with zero debt

Fully Equipped

The facility has an electrical sub-station on site, natural gas lines, multiple water-intakes, rail lines directly into the facility and 26 loading docks

Strategic Investments

We have made two strategic investments that we believe will deliver long-term value to our shareholders and support our operation FV Pharma:

Cannara Biotech

FV Pharma currently owns 25% of Canarra, which plans to be the largest indoor cultivation facility in Quebec and recently purchased a modern 625,000 sq. ft. facility on 27 acres of land, located less than one hour drive from Montreal.

View Website

High-Tide Ventures

A fully integrated retail distribution company that has applied for 31 retail cannabis permits in Alberta and 16 in Saskatchewan, with application expected to be submitted for British Columbia shortly. The company owns four of Canadas most prominent retail brands that are poised to take advantage of the legal recreational market in Canada which is anticipated to be enacted into law in fall of 2018.

View Website

Investors

Current Expansion 1 Expansion 2
Total Facility (S1. ft) 25,000 Sq. ft. 820,000 Sq. ft. 3,896,000 Sq. ft.

Current

Total Facility (S1. ft) 25,000 Sq. ft.

Expansion 1

Total Facility (S1. ft) 820,000 Sq. ft.

Expansion 2

Total Facility (S1. ft) 3,896,000 Sq. ft.

News

Announcing Closing of Business Combination and Conditional Approval from the CSE

May 25, 2018

May 25, 2018, Toronto, ON – FSD Pharma Inc. (formerly, Century Financial Capital Group Inc., the "Corporation") is pleased to announce that it has completed its previously announced business combination with FV Pharma Inc. ("FV Pharma").

Download PDF

FSD Pharma Commences Trading on CSE

May 29, 2018

TORONTO, Canada - May 29, 2018, FSD Pharma Inc. (“FSD” or the “Company”) (CSE:HUGE), a Canadian cannabis company focused on building the world’s largest indoor hydroponic cultivation and processing facility through its wholly owned subsidiary FV Pharma Inc.

Download PDF

FSD Broke All-Time Daily Volume Record

May 31, 2018

TORONTO, Canada - May 31, 2018, FSD Pharma Inc. (“FSD” or the “Company”) (CSE:HUGE), is pleased to report that on its first day of trading (May 29, 2018) the company traded exactly 78,477,861 Class B subordinate voting shares on the CSE...

Download Doc

FSD Secures Exclusive Canadian Rights to Proprietary Product Line and Access to Cannabinoid Research Platform in Israel

June 6, 2018

TORONTO, Canada - FSD Pharma Inc. (the “Company”) (CSE:HUGE), is pleased to announce that its wholly- owned subsidiary FV Pharma Inc (“FV Pharma”) have entered into a strategic alliance with SciCann Therapeutics Inc.

Download PDF

FSD Breaks All-Time Weekly Volume Trading Record

June 7, 2018

TORONTO, Canada - FSD Pharma Inc. (“FSD” or the “Company”) (CSE:HUGE), is pleased to report that in the first 5 consecutive days of trading, the company traded exactly 259,230,820 Class B subordinate voting shares on the Canadian Securities Exchange (“CSE”).

Download PDF

World-Class Partners

We strategically joint ventured with Cannabis Wheaton Income Corp. (TSX.V:CBW) (“Wheaton”), the world’s first cannabis streaming company. We partnered in an ongoing effort to build a world-class team successfully execute our business plan to build the world’s largest indoor growing operation. Our joint-venture with Wheaton allows us to mitigate risks and deploy capital responsibly by drawing on the rich knowhow of the highly experienced team at Wheaton and management team of FV Pharma.

Highlights of the Joint Venture

  • Wheaton will develop and finance all aspects of FV Pharma’s buildout at the former Kraft Facility in mutually agreed phases beginning in 2018
  • Wheaton will assist in the marketing, branding and distribution of the cannabis and cannabis derived products at the facility
  • FSD will receive stream of 50.1% and retrieves all costs
  • At full capacity, Wheaton estimates the facility to produce 400,000,000 grams of cannabis per annum

Team

  • Thomas Fairfull

    President, CEO and Director

  • Zeeshan Saeed

    Executive Vice President and Director

  • Michael Ash

    Chief Commercial Officer

  • Donal Carroll, CPA

    Director

  • Gerald Goldberg, CPA, CA

    Director

  • Vladimir Klacar

    Director

Company

  • Legal Counsel

    Bennet Jones, LLP

  • Auditor

    Dale Matheson Carr-Hilton Labonte LLP

  • Fiscal Year End

    December 31

  • CUSIP

    35954B

  • ISIN

    CA1562N2077

  • Jurisdisction

    Ontario, Canada

  • Transfer Agent

    Computershare Trust Corporation

  • Capital Structure - Issued & Outstanding Basic

    1,319,600,458

  • Capital Structure - Issued & Outstanding Fully Diluted

    1,531,842,915

k